Malmberg KJ - Search Results

1

An optimized platform for efficient siRNA delivery into human NK cells.

Palacios D, Momayyezi P, Huhn O, Ask EH, Dunst J, Malmberg KJ, Hammer Q. Palacios D, et al. Among authors: malmberg kj. Eur J Immunol. 2022 Jul;52(7):1190-1193. doi: 10.1002/eji.202149710. Epub 2022 Apr 22. Eur J Immunol. 2022. PMID: 35416292 Free PMC article.

2

KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation.

Malmberg KJ, Schaffer M, Ringdén O, Remberger M, Ljunggren HG. Malmberg KJ, et al. Mol Immunol. 2005 Feb;42(4):531-4. doi: 10.1016/j.molimm.2004.07.037. Mol Immunol. 2005. PMID: 15607809 Review.

3

Prospects for the use of NK cells in immunotherapy of human cancer.

Ljunggren HG, Malmberg KJ. Ljunggren HG, et al. Among authors: malmberg kj. Nat Rev Immunol. 2007 May;7(5):329-39. doi: 10.1038/nri2073. Nat Rev Immunol. 2007. PMID: 17438573 Review.

4

The CD16- CD56(bright) NK cell subset is resistant to reactive oxygen species produced by activated granulocytes and has higher antioxidative capacity than the CD16+ CD56(dim) subset.

Harlin H, Hanson M, Johansson CC, Sakurai D, Poschke I, Norell H, Malmberg KJ, Kiessling R. Harlin H, et al. Among authors: malmberg kj. J Immunol. 2007 Oct 1;179(7):4513-9. doi: 10.4049/jimmunol.179.7.4513. J Immunol. 2007. PMID: 17878347

5

NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy.

Malmberg KJ, Bryceson YT, Carlsten M, Andersson S, Björklund A, Björkström NK, Baumann BC, Fauriat C, Alici E, Dilber MS, Ljunggren HG. Malmberg KJ, et al. Cancer Immunol Immunother. 2008 Oct;57(10):1541-52. doi: 10.1007/s00262-008-0492-7. Epub 2008 Mar 4. Cancer Immunol Immunother. 2008. PMID: 18317755 Free PMC article. Review.

6

Elevated numbers of Fc gamma RIIIA+ (CD16+) effector CD8 T cells with NK cell-like function in chronic hepatitis C virus infection.

Björkström NK, Gonzalez VD, Malmberg KJ, Falconer K, Alaeus A, Nowak G, Jorns C, Ericzon BG, Weiland O, Sandberg JK, Ljunggren HG. Björkström NK, et al. Among authors: malmberg kj. J Immunol. 2008 Sep 15;181(6):4219-28. doi: 10.4049/jimmunol.181.6.4219. J Immunol. 2008. PMID: 18768879

7

Estimation of the size of the alloreactive NK cell repertoire: studies in individuals homozygous for the group A KIR haplotype.

Fauriat C, Andersson S, Björklund AT, Carlsten M, Schaffer M, Björkström NK, Baumann BC, Michaëlsson J, Ljunggren HG, Malmberg KJ. Fauriat C, et al. Among authors: malmberg kj. J Immunol. 2008 Nov 1;181(9):6010-9. doi: 10.4049/jimmunol.181.9.6010. J Immunol. 2008. PMID: 18941190

8

Natural killer cell-mediated lysis of freshly isolated human tumor cells.

Carlsten M, Malmberg KJ, Ljunggren HG. Carlsten M, et al. Among authors: malmberg kj. Int J Cancer. 2009 Feb 15;124(4):757-62. doi: 10.1002/ijc.24082. Int J Cancer. 2009. PMID: 19035446 Review.

9

Spotlight on IL-22-producing NK cell receptor-expressing mucosal lymphocytes.

Malmberg KJ, Ljunggren HG. Malmberg KJ, et al. Nat Immunol. 2009 Jan;10(1):11-2. doi: 10.1038/ni0109-11. Nat Immunol. 2009. PMID: 19088733

10

Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells.

Carlsten M, Norell H, Bryceson YT, Poschke I, Schedvins K, Ljunggren HG, Kiessling R, Malmberg KJ. Carlsten M, et al. Among authors: malmberg kj. J Immunol. 2009 Oct 15;183(8):4921-30. doi: 10.4049/jimmunol.0901226. J Immunol. 2009. PMID: 19801517

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters